Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Branched-chain amino acids reduce hindlimb suspension-induced muscle atrophy and protein levels of atrogin-1 and MuRF1 in rats.

Maki T, Yamamoto D, Nakanishi S, Iida K, Iguchi G, Takahashi Y, Kaji H, Chihara K, Okimura Y.

Nutr Res. 2012 Sep;32(9):676-83. doi: 10.1016/j.nutres.2012.07.005. Epub 2012 Sep 17.

PMID:
23084640
2.

Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1.

Bodine SC, Baehr LM.

Am J Physiol Endocrinol Metab. 2014 Sep 15;307(6):E469-84. doi: 10.1152/ajpendo.00204.2014. Epub 2014 Aug 5. Review.

3.

The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy.

Foletta VC, White LJ, Larsen AE, L├ęger B, Russell AP.

Pflugers Arch. 2011 Mar;461(3):325-35. doi: 10.1007/s00424-010-0919-9. Epub 2011 Jan 11. Review.

PMID:
21221630
4.

Atrogin-1, MuRF-1, and sarcopenia.

Gumucio JP, Mendias CL.

Endocrine. 2013 Feb;43(1):12-21. doi: 10.1007/s12020-012-9751-7. Epub 2012 Jul 20. Review.

5.

Oxidative stress and disuse muscle atrophy: cause or consequence?

Powers SK, Smuder AJ, Judge AR.

Curr Opin Clin Nutr Metab Care. 2012 May;15(3):240-5. doi: 10.1097/MCO.0b013e328352b4c2. Review.

6.

Skeletal muscle atrophy: disease-induced mechanisms may mask disuse atrophy.

Malavaki CJ, Sakkas GK, Mitrou GI, Kalyva A, Stefanidis I, Myburgh KH, Karatzaferi C.

J Muscle Res Cell Motil. 2015 Dec;36(6):405-21. doi: 10.1007/s10974-015-9439-8. Epub 2016 Jan 4. Review.

PMID:
26728748
7.

The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy.

Murton AJ, Constantin D, Greenhaff PL.

Biochim Biophys Acta. 2008 Dec;1782(12):730-43. doi: 10.1016/j.bbadis.2008.10.011. Epub 2008 Oct 29. Review.

8.

Branched-chain amino acids and ammonia metabolism in liver disease: therapeutic implications.

Holecek M.

Nutrition. 2013 Oct;29(10):1186-91. doi: 10.1016/j.nut.2013.01.022. Epub 2013 Jun 4. Review.

PMID:
23756281
9.

Redox homeostasis, oxidative stress and disuse muscle atrophy.

Pellegrino MA, Desaphy JF, Brocca L, Pierno S, Camerino DC, Bottinelli R.

J Physiol. 2011 May 1;589(Pt 9):2147-60. doi: 10.1113/jphysiol.2010.203232. Epub 2011 Feb 14. Review.

10.

Insulinotropic and muscle protein synthetic effects of branched-chain amino acids: potential therapy for type 2 diabetes and sarcopenia.

Manders RJ, Little JP, Forbes SC, Candow DG.

Nutrients. 2012 Nov 8;4(11):1664-78. doi: 10.3390/nu4111664. Review.

11.

[Development of ubiquitin ligase inhibitor as a drug against unloading-mediated muscle atrophy].

Nikawa T.

Seikagaku. 2009 Jul;81(7):614-8. Review. Japanese. No abstract available.

PMID:
19697867
12.

Can antioxidants protect against disuse muscle atrophy?

Powers SK.

Sports Med. 2014 Nov;44 Suppl 2:S155-65. doi: 10.1007/s40279-014-0255-x. Review.

13.

Novel metabolic and physiological functions of branched chain amino acids: a review.

Zhang S, Zeng X, Ren M, Mao X, Qiao S.

J Anim Sci Biotechnol. 2017 Jan 23;8:10. doi: 10.1186/s40104-016-0139-z. eCollection 2017. Review.

14.
15.

Emerging Roles of Branched-Chain Amino Acid Supplementation in Human Diseases.

Tamanna N, Mahmood N.

Int Sch Res Notices. 2014 Nov 12;2014:235619. doi: 10.1155/2014/235619. eCollection 2014. Review.

16.

Control of skeletal muscle atrophy in response to disuse: clinical/preclinical contentions and fallacies of evidence.

Atherton PJ, Greenhaff PL, Phillips SM, Bodine SC, Adams CM, Lang CH.

Am J Physiol Endocrinol Metab. 2016 Sep 1;311(3):E594-604. doi: 10.1152/ajpendo.00257.2016. Epub 2016 Jul 5. Review.

PMID:
27382036

Supplemental Content

Support Center